{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:10:54Z","timestamp":1786975854980,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd004364","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T00:00:00Z","timestamp":1169596800000}}],"reference-count":149,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004364.pub2","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T08:35:23Z","timestamp":1169714123000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia"],"prefix":"10.1002","volume":"2010","author":[{"given":"Toshi A","family":"Furukawa","sequence":"first","affiliation":[{"name":"Nagoya City University Graduate School of Medical Sciences; Department of Psychiatry & Cognitive-Behavioral Medicine; Mizuho-cho, Mizuho-ku Nagoya Aichi Japan 467-8601"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Nagoya City University Graduate School of Medical Sciences; Department of Psychiatry & Cognitive-Behavioral Medicine; Mizuho-cho, Mizuho-ku Nagoya Aichi Japan 467-8601"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[{"name":"University of Bristol; Academic Unit of Psychiatry, Community Based Medicine; Cotham House, Cotham Hill Bristol Avon UK BS6 6JL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD004364.pub2-BIB0001|cit1","first-page":"402","article-title":"Comparison of fluvoxamine alone, fluvoxamine and cognitive psychotherapy and psychotherapy alone in the treatment of panic disorder in Kelantan--implications for management by family doctors","volume":"55","author":"Azhar","year":"2000","journal-title":"Medical Journal of Malaysia"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/da.10087","article-title":"The effect of pharmacotherapist characteristics on treatment outcome in panic disorder","volume":"17","author":"Gorman","year":"2003","journal-title":"Depression and Anxiety"},{"issue":"6","key":"10.1002\/14651858.CD004364.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0010-440X(98)90043-8","article-title":"Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder","volume":"39","author":"Grilo","year":"1998","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1176\/ajp.155.1.43","article-title":"Pretreatment attrition in a comparative treatment outcome study on panic disorder","volume":"155","author":"Hofmann","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<14::AID-DA3>3.0.CO;2-5","article-title":"Effects of panic disorder treatments on personality disorder characteristics","volume":"8","author":"Hofmann","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1037\/0022-006X.69.5.747","article-title":"Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder","volume":"69","author":"Huppert","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/da.10087","article-title":"The effect of pharmacotherapist characteristics on treatment outcome in panic disorder","volume":"17","author":"Gorman","year":"2003","journal-title":"Depression and Anxiety"},{"issue":"6","key":"10.1002\/14651858.CD004364.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0010-440X(98)90043-8","article-title":"Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder","volume":"39","author":"Grilo","year":"1998","journal-title":"Comprrehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1176\/ajp.155.1.43","article-title":"Pretreatment attrition in a comparative treatment outcome study on panic disorder","volume":"155","author":"Hofmann","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<14::AID-DA3>3.0.CO;2-5","article-title":"Effects of panic disorder treatments on personality disorder characteristics","volume":"8","author":"Hofmann","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1037\/0022-006X.69.5.747","article-title":"Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder","volume":"69","author":"Huppert","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/da.10087","article-title":"The effect of pharmacotherapist characteristics on treatment outcome in panic disorder","volume":"17","author":"Gorman","year":"2003","journal-title":"Depression and Anxiety"},{"issue":"6","key":"10.1002\/14651858.CD004364.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0010-440X(98)90043-8","article-title":"Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder","volume":"39","author":"Grilo","year":"1998","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1176\/ajp.155.1.43","article-title":"Pretreatment attrition in a comparative treatment outcome study on panic disorder","volume":"155","author":"Hofmann","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<14::AID-DA3>3.0.CO;2-5","article-title":"Effects of panic disorder treatments on personality disorder characteristics","volume":"8","author":"Hofmann","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1037\/0022-006X.69.5.747","article-title":"Therapists, therapist variables, and cognitive-behavioral therapy outcome in a multicenter trial for panic disorder","volume":"69","author":"Huppert","year":"2001","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-0327(03)00043-0","article-title":"Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder","volume":"80","author":"Berger","year":"2004","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0021|cit21","unstructured":"Berger P Sachs G Amering M Holzinger A Maierhofer D Bankier B Predictors of treatment-response in panic disorder 151st Annual Meeting of the American Psychiatric Association 1998"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0022|cit22","unstructured":"Katschnig H Berger P Sachs G Amering M Holzinger A Maierhofer D Drugs and psychotherapy in panic disorder: methodological issues 151st Annual Meeting of the American Psychiatric Association 1998"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/ajp.152.5.683","article-title":"Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone","volume":"152","author":"Beurs","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.1999.tb05385.x","article-title":"Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up","volume":"99","author":"Beurs","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cpp.5640020203","article-title":"Perceived upbringing and its relation to treatment outcome in agoraphobia","volume":"2","author":"Beurs","year":"1995","journal-title":"Clinical Psychology and Psychotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","article-title":"Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia","volume":"184","author":"Balkom","year":"1996","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"van Balkom AJ de Beurs E van Dyck R Lange A Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress 8th European College of Neuropsychopharmacology Congress 1995","DOI":"10.1016\/0924-977X(96)87819-9"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/ajp.152.5.683","article-title":"Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone","volume":"152","author":"Beurs","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.1999.tb05385.x","article-title":"Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up","volume":"99","author":"Beurs","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cpp.5640020203","article-title":"Perceived upbringing and its relation to treatment outcome in agoraphobia","volume":"2","author":"Beurs","year":"1995","journal-title":"Clinical Psychology and Psychotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","article-title":"Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia","volume":"184","author":"Balkom","year":"1996","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"van Balkom AJ de Beurs E van Dyck R Lange A Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress 8th European College of Neuropsychopharmacology Congress 1995","DOI":"10.1016\/0924-977X(96)87819-9"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/ajp.152.5.683","article-title":"Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone","volume":"152","author":"Beurs","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.1999.tb05385.x","article-title":"Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up","volume":"99","author":"Beurs","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cpp.5640020203","article-title":"Perceived upbringing and its relation to treatment outcome in agoraphobia","volume":"2","author":"Beurs","year":"1995","journal-title":"Clinical Psychology and Psychotherapy"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","article-title":"Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia","volume":"184","author":"Balkom","year":"1996","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"van Balkom AJ de Beurs E van Dyck R Lange A Two-year follow-up after treatment of panic disorder with agoraphobia. 8th European College of Neuropsychopharmacology Congress 8th European College of Neuropsychopharmacology Congress 1995","DOI":"10.1016\/0924-977X(96)87819-9"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-0327(92)90094-M","article-title":"The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial","volume":"25","author":"Fahy","year":"1992","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1192\/bjp.168.4.462","article-title":"The Galway study of panic disorder III: Outcome at 5 to 6 years","volume":"168","author":"O'Rourke","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0447.1997.tb09636.x","article-title":"Overcoming resistance to exposure in panic disorder with agoraphobia","volume":"95","author":"Fava","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0041|cit41","first-page":"192","article-title":"Clomipramine therapy and behavior therapy with agoraphobic women","volume":"40","author":"Johnson","year":"1995","journal-title":"Canadian Journal of Psychiatry - Revue Canadienne De Psychiatrie"},{"issue":"9","key":"10.1002\/14651858.CD004364.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.v63n0904","article-title":"A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone","volume":"63","author":"Kampman","year":"2002","journal-title":"Journal of Clinial Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.174.3.205","article-title":"Randomised placebo-controlled trial of moclobemide, cognitive- behavioural therapy and their combination in panic disorder with agoraphobia","volume":"174","author":"Loerch","year":"1999","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1192\/bjp.144.3.276","article-title":"Two-year follow-up of agoraphobics after exposure and imipramine","volume":"144","author":"Cohen","year":"1984","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004364.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00005053-198710000-00004","article-title":"Agoraphobics 5 years after imipramine and exposure. Outcome and predictors","volume":"175","author":"Lelliott","year":"1987","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1983.01790020047004","article-title":"Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework","volume":"40","author":"Marks","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1192\/bjp.143.4.348","article-title":"Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice","volume":"143","author":"Mavissakalian","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0053|cit48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-3956(93)90027-Y","article-title":"Combined behavioral-therapy and pharmacotherapy of agoraphobia","volume":"27","author":"Mavissakalian","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0048|cit49","first-page":"91","article-title":"Agoraphobia: behavioral and pharmacological treatments, preliminary outcome, and process findings","volume":"18","author":"Mavissakalian","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0049|cit50","first-page":"117","article-title":"Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine","volume":"47","author":"Mavissakalian","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0050|cit51","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0005-7894(83)80074-4","article-title":"Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia","volume":"14","author":"Mavissakalian","year":"1983","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0051|cit52","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/ajp.143.9.1106","article-title":"Two-year follow-up of exposure and imipramine treatment of agoraphobia","volume":"143","author":"Mavissakalian","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0052|cit53","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/ajp.142.9.1032","article-title":"Imipramine in the treatment of agoraphobia: dose-response relationships","volume":"142","author":"Mavissakalian","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0059|cit54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-3956(93)90027-Y","article-title":"Combined behavioral-therapy and pharmacotherapy of agoraphobia","volume":"27","author":"Mavissakalian","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0054|cit55","first-page":"91","article-title":"Agoraphobia: behavioral and pharmacological treatments, preliminary outcome, and process findings","volume":"18","author":"Mavissakalian","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0055|cit56","first-page":"117","article-title":"Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine","volume":"47","author":"Mavissakalian","year":"1986","journal-title":"Journal of Clinial Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0056|cit57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0005-7894(83)80074-4","article-title":"Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia","volume":"14","author":"Mavissakalian","year":"1983","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0057|cit58","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/ajp.143.9.1106","article-title":"Two-year follow-up of exposure and imipramine treatment of agoraphobia","volume":"143","author":"Mavissakalian","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0058|cit59","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/ajp.142.9.1032","article-title":"Imipramine in the treatment of agoraphobia: dose-response relationships","volume":"142","author":"Mavissakalian","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","article-title":"Paroxetine in the treatment of panic disorder. A randomised, double- blind, placebo-controlled study","volume":"167","author":"Oehrberg","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004364.pub2-BIB0063|cit61","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1099-0879(199911)6:5<336::AID-CPP205>3.0.CO;2-H","article-title":"Predicting treatment outcome for panic disorder and agoraphobia in primary care","volume":"6","author":"Sharp","year":"1999","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0064|cit62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1352465898000034","article-title":"Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care","volume":"26","author":"Sharp","year":"1998","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004364.pub2-BIB0065|cit63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/026988119701100415","article-title":"Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies","volume":"11","author":"Sharp","year":"1997","journal-title":"Journal of Psychopharmacology"},{"issue":"416","key":"10.1002\/14651858.CD004364.pub2-BIB0061|cit64","first-page":"150","article-title":"Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care","volume":"47","author":"Sharp","year":"1997","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0062|cit65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia","volume":"10","author":"Sharp","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004364.pub2-BIB0068|cit66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1099-0879(199911)6:5<336::AID-CPP205>3.0.CO;2-H","article-title":"Predicting treatment outcome for panic disorder and agoraphobia in primary care","volume":"6","author":"Sharp","year":"1999","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0069|cit67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1352465898000034","article-title":"Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care","volume":"26","author":"Sharp","year":"1998","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004364.pub2-BIB0070|cit68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/026988119701100415","article-title":"Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies","volume":"11","author":"Sharp","year":"1997","journal-title":"Journal of Psychopharmacology"},{"issue":"416","key":"10.1002\/14651858.CD004364.pub2-BIB0066|cit69","first-page":"150","article-title":"Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care","volume":"47","author":"Sharp","year":"1997","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0067|cit70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia","volume":"10","author":"Sharp","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004364.pub2-BIB0073|cit71","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1099-0879(199911)6:5<336::AID-CPP205>3.0.CO;2-H","article-title":"Predicting treatment outcome for panic disorder and agoraphobia in primary care","volume":"6","author":"Sharp","year":"1999","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0074|cit72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1352465898000034","article-title":"Psychologist, patient, and general practitioneer ratings of outcome of pharmacological and psychological treatments for panic disorder and agoraphobia in primary care","volume":"26","author":"Sharp","year":"1998","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"4","key":"10.1002\/14651858.CD004364.pub2-BIB0075|cit73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/026988119701100415","article-title":"Treatment-outcome research in panic disorder: Dilemmas in reconciling the demands of pharmacological and psychological methodologies","volume":"11","author":"Sharp","year":"1997","journal-title":"Journal of Psychopharmacology"},{"issue":"416","key":"10.1002\/14651858.CD004364.pub2-BIB0071|cit74","first-page":"150","article-title":"Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care","volume":"47","author":"Sharp","year":"1997","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0072|cit75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0887-6185(96)00008-4","article-title":"Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of ppanic disorder and agoraphobia","volume":"10","author":"Sharp","year":"1996","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","article-title":"Treatment of endogenous anxiety with phobic, hysterical, and hypochondriachal symptoms","volume":"37","author":"Sheehan","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archpsyc.1980.01780140053006","article-title":"Treatment of endogenous anxiety with phobic, hysterical, and hypochondriachal symptoms","volume":"37","author":"Sheehan","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1099-0879(199606)3:2<86::AID-CPP91>3.0.CO;2-3","article-title":"Panic management, trazodone and a combination of both in the treatment of panic disorder","volume":"3","author":"Spinhoven","year":"1996","journal-title":"Clinical Psychology and Psychotherapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-1781(00)00154-2","article-title":"Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study","volume":"94","author":"Stein","year":"2000","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-1781(88)90145-X","article-title":"Autonomic changes after treatment of agoraphobia with panic attacks","volume":"24","author":"Roth","year":"1988","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0005-7967(85)90011-7","article-title":"Combined pharmacological and behavioral treatment for agoraphobia","volume":"23","author":"Telch","year":"1985","journal-title":"Behavior Research and Therapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Dahl AA Wiborg IM Pharmacotherapy and brief dynamic psychotherapy of panic disorder 9th European College of Neuropsychopharmacology Congress Amsterdam, The Netherlands 1996","DOI":"10.1016\/0924-977X(96)83138-5"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archpsyc.1996.01830080041008","article-title":"Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?","volume":"53","author":"Wiborg","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0084|cit84","unstructured":"Wiborg IM Dahl AA Pharmacotherapy and brief dynamic psychotherapy of panic disorder Xth World Congress of Psychiatry Madrid, Spain 1996"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0086|cit85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0005-7916(83)90006-X","article-title":"Differential treatment of phobias: Use of imipramine for panic attacks","volume":"14","author":"Zitrin","year":"1983","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0085|cit86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1980.01780140065007","article-title":"Treatment of agoraphobia with group exposure in vivo and imipramine","volume":"37","author":"Zitrin","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004364.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1987.01800160093011","article-title":"Panic and avoidance in agoraphobia. Application of path analysis to treatment studies","volume":"44","author":"Klein","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1983.01790020033003","article-title":"Treatment of phobias. II. Behavior therapy and supportive psychotherapy: are there any specific ingredients?","volume":"40","author":"Klein","year":"1983","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004364.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1520-6394(1999)10:3<105::AID-DA3>3.0.CO;2-X","article-title":"Specific phobia 10-16 years after treatment","volume":"10","author":"Lipsitz","year":"1999","journal-title":"Depression and Anxiety"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0094|cit90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0005-7916(83)90006-X","article-title":"Differential treatment of phobias: Use of imipramine for panic attacks","volume":"14","author":"Zitrin","year":"1983","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0090|cit91","first-page":"233","article-title":"Comparison of short-term treatment regimens in phobic patients: a preliminary report","volume-title":"Evaluation of Psychological Therapies","author":"Zitrin","year":"1976"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archpsyc.1978.01770270057005","article-title":"Behavior therapy, supportive psychotherapy, imipramine, and phobias","volume":"35","author":"Zitrin","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0091|cit93","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","article-title":"Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo","volume":"40","author":"Zitrin","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0093|cit94","article-title":"Differentiation of panic anxiety from anticipatory anxiety and avoidance behavior","volume-title":"Anxiety: New Research and Changing Concepts","author":"Zitrin","year":"1981"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0095|cit95","unstructured":"Agras WS Telch MJ Taylor CB Roth WT Brouillard M Imipramine and exposure therapy in agoraphobia: untangling the actions and interactions Telch and Lucas (1984)"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0096|cit96","unstructured":"Ba G Vigano C Integrated therapy of panic disorder: a controlled study 152nd Annual Meeting of the American Psychiatric Association Washington DC, USA 1999"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0097|cit97","unstructured":"Ba G Vigano C Integrated therapy of panic disorders: a controlled study Unpublished manuscript"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0098|cit98","unstructured":"Vigano C Bielli A Carozzi A Divino T Pagliarulo E Ba G Panic disorder: A two-year follow-up of an integrated treatment approach. Italian Journal of Psychopathology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-7967(82)90140-1","article-title":"Exposure and communications training in the treatment of agoraphobia","volume":"20","author":"Chambless","year":"1982","journal-title":"Behavior Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD004364.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0005-7967(79)90039-1","article-title":"Flooding with Brevital in the treatment of agoraphobia: countereffective?","volume":"17","author":"Chambless","year":"1979","journal-title":"Behavior Research and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0005-7916(88)90025-0","article-title":"Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia","volume":"19","author":"Cox","year":"1988","journal-title":"Journal of Behavior Therapy and Experimental Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00421708","article-title":"The management of severe agoraphobia: a comparison of ipronizaid and systematic desensitization","volume":"32","author":"Lipsedge","year":"1973","journal-title":"Psychopharmacologia"},{"issue":"3","key":"10.1002\/14651858.CD004364.pub2-BIB0103|cit103","first-page":"239","article-title":"Phenelzine and exposure in the treatment of phobias","volume":"16","author":"Solyom","year":"1981","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0104|cit104","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder","volume":"155 Supplement","author":"American Psychiatric Association","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1037\/0022-006X.63.5.754","article-title":"Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment","volume":"63","author":"Brown","year":"1995","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"6","key":"10.1002\/14651858.CD004364.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0005-7894(86)80096-X","article-title":"Agoraphobia 8 years after behavioral treatment: a follow-up study with interview, self-report, and behavioral data","volume":"17","author":"Burns","year":"1986","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00127-002-0542-y","article-title":"12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population","volume":"37","author":"Carlbring","year":"2002","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/ajp.147.4.507","article-title":"Surreptitious drug use by patients in a panic disorder study","volume":"147","author":"Calrk","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1037\/0022-006X.61.2.317","article-title":"A meta-analysis of treatments for panic disorder","volume":"61","author":"Clum","year":"1993","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy. I: medical","volume":"9","author":"Coldiz","year":"1989","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1017\/S0033291701003592","article-title":"Long-term outcome of panic disorder with agoraphobia treated by exposure","volume":"31","author":"Fava","year":"2001","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0006-3223(02)01552-4","article-title":"Context in the clinic: How well do cognitive-behavioral therapies and medications work in combination?","volume":"52","author":"Foa","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"Can we individualize the Number Needed to Treat (NNT)? An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analysis","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1176\/ajp.152.10.1438","article-title":"DSM-IV and the disappearnace of agoraphobia without history of panic disorder: new data on a controversial diagnosis","volume":"152","author":"Goisman","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0272-7358(95)00048-8","article-title":"A meta-analysis of treatment outcome for panic disorder","volume":"15","author":"Gould","year":"1995","journal-title":"Clinical Psychology Review"},{"issue":"7414","key":"10.1002\/14651858.CD004364.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1037\/0033-2909.90.3.467","article-title":"Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug-psychotherapy comparative trials","volume":"90","author":"Hollon","year":"1981","journal-title":"Psychological Bulletin"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1176\/appi.ajp.157.8.1204","article-title":"Flawed meta-analyses comparing psychotherapy with pharmacotherapy","volume":"157","author":"Klein","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00005053-199009000-00003","article-title":"Treatment of panic and agoraphobia: an integrative review","volume":"178","author":"Mattick","year":"1990","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0022-3956(93)90027-Y","article-title":"Combined behavioral therapy and pharmacotherapy of agoraphobia","volume":"27 Suppl 1","author":"Mavissakalian","year":"1993","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004714-200206000-00010","article-title":"Duration of imipramine therapy and relapse in panic disorder with agoraphobia","volume":"22","author":"Mavissakalian","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0130|cit130","volume-title":"A Guide to Treatments that Work","author":"Nathan","year":"2002"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0005-7894(96)80028-1","article-title":"Maintenance of remission following cognitive behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment","volume":"27","author":"Otto","year":"1996","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1037\/0022-006X.68.4.556","article-title":"Empirically supported treatments for panic disorder: costs, benefits, and stepped care","volume":"68","author":"Otto","year":"2000","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archpsyc.1988.01800290043006","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects","volume":"45","author":"Pecknold","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S109285290000691X","article-title":"WCA recommendations for the long-term treatment of panic disorder","volume":"8","author":"Pollack","year":"2003","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1026207414971","article-title":"Panic disorder: cognitive behavioral and pharmacological treatment strategies","volume":"6","author":"Schmidt","year":"1999","journal-title":"Journal of Clinical Psychology in Medical Settings"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/10415-004","article-title":"Combined treatments for phobic anxiety disorders","volume-title":"Combined Treatments for Mental Disorders: A Guide to Psychological and Pharmacological Interventions","author":"Schmidt","year":"2001"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(01)00359-7","article-title":"Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder","volume":"69","author":"Simon","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"7387","key":"10.1002\/14651858.CD004364.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","article-title":"Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses","volume":"326","author":"Song","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0141|cit141","volume-title":"Understanding and Treating Panic Disorder","author":"Taylor","year":"2000"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0142|cit142","first-page":"177","article-title":"A. Combined pharmacological and psychological tretment of panic disorder: Current status and future directions.","volume-title":"Treatment of Panic Disorder: A Consensus Development Conference","author":"Telch","year":"1994"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2000-11221","article-title":"A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants","volume":"33","author":"Toni","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004364.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005053-199602000-00015","article-title":"Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia","volume":"184","author":"Balkom","year":"1996","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-199708000-00006","article-title":"A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments","volume":"185","author":"Balkom","year":"1997","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD004364.pub2-BIB0146|cit146","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005335","article-title":"Combined psychotherapy plus benzodiazepines for panic disorder with or without agoraphobia [Protocol]","author":"Watanabe","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","article-title":"The cross-national epidemiology of panic disorder","volume":"54","author":"Weissman","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004364.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","article-title":"Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?","volume":"18","author":"Westra","year":"1998","journal-title":"Clinical Psychology Review"},{"key":"10.1002\/14651858.CD004364.pub2-BIB0149|cit149","unstructured":"World Health Report 2004 WHO"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004364.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:33:38Z","timestamp":1761204818000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004364.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":149,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004364.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,24]]}}}